(19)
(11) EP 0 870 028 A1

(12)

(43) Date of publication:
14.10.1998 Bulletin 1998/42

(21) Application number: 96944936.0

(22) Date of filing: 20.12.1996
(51) International Patent Classification (IPC): 
G01N 33/ 53( . )
A61K 38/ 00( . )
A61K 48/ 00( . )
A61P 43/ 00( . )
C07K 14/ 54( . )
C12N 15/ 19( . )
C12Q 1/ 68( . )
 A61K 31/ 00( . )
A61K 45/ 00( . )
A61P 37/ 00( . )
C07K 14/ 52( . )
C12N 15/ 09( . )
C12P 21/ 02( . )
G01N 33/ 566( . )
(86) International application number:
PCT/US1996/020432
(87) International publication number:
WO 1997/024441 (10.07.1997 Gazette 1997/30)
(84) Designated Contracting States:
BE DE ES FR GB IT NL

(30) Priority: 29.12.1995 US 19950580667

(71) Applicant: INCYTE PHARMACEUTICALS, INC.
Palo Alto, CA 94304 (US)

(72) Inventors:
  • COLEMAN, Roger
    Mountain View, CA 94041 (US)
  • COCKS, Benjamin, Graeme
    Palo Alto, CA 94306 (US)
  • HAWKINS, Phillip, R.
    Mountain View, CA 94304 (US)

(74) Representative: Wright, Simon Mark 
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) NUCLEIC ACIDS ENCODING INTERFERON GAMMA INDUCING FACTOR-2